Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes

被引:54
作者
Jacobs, Robert L. [1 ]
Harper, Nathan [2 ,3 ]
He, Weijing [2 ,3 ]
Andrews, Charles P. [1 ]
Rather, Cynthia G. [1 ]
Ramirez, Daniel A. [1 ]
Ahuja, Sunil K. [2 ,3 ,4 ,5 ]
机构
[1] Biogen Res Chamber LLC, San Antonio, TX 78229 USA
[2] S Texas Vet Hlth Care Syst, Vet Adm Ctr Personalized Med, San Antonio, TX USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA
基金
美国国家卫生研究院;
关键词
Allergic diseases; environmental chamber; ragweed; endotypes; VALIDATION; NASAL; RHINITIS; ASTHMA; ONSET; UNIT;
D O I
10.1016/j.jaci.2012.03.031
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The level of concordance between allergic symptoms induced on exposure to pollen in a pollen challenge chamber (PCC) versus the natural season is unknown. Objective: We sought to test the hypothesis that the symptom levels of allergic rhinoconjunctivitis elicited after out-of-season exposure to short ragweed in a PCC and during the natural season for giant ragweed pollen are highly correlated. Methods: Thirty-one ragweed-sensitive participants recorded symptoms for 15 days during the natural giant ragweed season in San Antonio, Texas. Twenty-six of these participants were challenged to short ragweed pollen in a PCC for 3 hours per day for up to 4 days. Results: In the PCC participants were dichotomized into those in whom low versus high levels of symptoms developed slowly or rapidly (ie, slow/low vs rapid/high). Each successive exposure visit associated with a progressive increase in symptom levels that approximated those experienced during the natural season. Hierarchic clustering identified 3 endotypes: endotypes I and II reflected concordantly low (n = 7) versus high (n = 14) total symptom scores (TSSs) in both the natural season and the PCC, respectively. Accordingly, the correlation between the TSSs recorded in the natural season and in the PCC for these 21 participants was very high. Although participants with endotype III (n = 5) had greater TSSs in the natural season than in the PCC, the degree of correlation between the TSSs remained high. Conclusions: Our findings affirm our hypothesis, underscore the high cross-reactivity between distinct pollens, and highlight the utility of the PCC to identify novel allergy endotypes that might have contrasting mechanistic underpinnings and potentially therapeutic responses. (J Allergy Clin Immunol 2012;130:122-7.)
引用
收藏
页码:122 / +
页数:14
相关论文
共 20 条
[1]  
Akerlund Anders, 2005, J Allergy Clin Immunol, V115, pS460, DOI 10.1016/j.jaci.2004.12.016
[2]   ALLERGEN-INDUCED NASAL HYPERREACTIVITY APPEARS UNRELATED TO THE SIZE OF THE NASAL AND DERMAL IMMEDIATE ALLERGIC REACTION [J].
ANDERSSON, M ;
VONKOGERER, B ;
ANDERSSON, P ;
PIPKORN, U .
ALLERGY, 1987, 42 (08) :631-637
[3]   Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: Analysis of the allergenic differences between short and giant ragweed [J].
Asero, R ;
Weber, B ;
Mistrello, G ;
Amato, S ;
Madonini, E ;
Cromwell, O .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) :1036-1041
[4]   PRIMING OF THE NASAL-MUCOSA BY RAGWEED EXTRACT OR BY AN IRRITANT (AMMONIA) [J].
BACON, JR ;
MCLEAN, JA ;
MATHEWS, KP ;
BANAS, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1981, 67 (02) :111-116
[5]   Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season [J].
Badorrek, Philipp ;
Dick, Melanie ;
Hecker, Hartmut ;
Schaumann, Frank ;
Sousa, Ana R. ;
Murdoch, Robert ;
Hohlfeld, Jens M. ;
Krug, Norbert .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 106 (04) :336-341
[6]   Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit [J].
Berkowitz, RB ;
Woodworth, GG ;
Lutz, C ;
Weiler, K ;
Weiler, J ;
Moss, M ;
Meeves, S .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 89 (01) :38-45
[7]   INVITRO CROSS-ALLERGENICITY OF MAJOR AEROALLERGENIC POLLENS BY RADIOALLERGOSORBENT TECHNIQUE [J].
BERNSTEIN, IL ;
PERERA, M ;
GALLAGHER, J ;
MICHAEL, JG ;
JOHANSSON, SGO .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1976, 57 (02) :141-152
[8]   Lebrikizumab Treatment in Adults with Asthma [J].
Corren, Jonathan ;
Lemanske, Robert F., Jr. ;
Hanania, Nicola A. ;
Korenblat, Phillip E. ;
Parsey, Merdad V. ;
Arron, Joseph R. ;
Harris, Jeffrey M. ;
Scheerens, Heleen ;
Wu, Lawren C. ;
Su, Zheng ;
Mosesova, Sofia ;
Eisner, Mark D. ;
Bohen, Sean P. ;
Matthews, John G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) :1088-1098
[9]   Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit [J].
Day, James H. ;
Briscoe, Maureen P. ;
Ratz, Jodan D. ;
Ellis, Anne K. ;
Yao, Ruji ;
Danzig, Melvyn .
ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (03) :270-276
[10]   Environmental exposure unit: a system to test anti-allergic treatment [J].
Day, JH ;
Briscoe, MP .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 83 (02) :83-93